Illumina To Webcast Upcoming Investor Conferences
Illumina (NASDAQ: ILMN) announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Illumina (NASDAQ: ILMN) announced its participation in two upcoming investor conferences. The SVB Leerink 2022 Global Healthcare Conference will feature a fireside chat on February 17, 2022, at 9:00 AM PT. The Citi 2022 Healthcare Conference will follow with another chat on February 24, 2022, at 9:30 AM PT. Both events will be accessible via live webcast through Illumina's website, with replays available for at least 30 days afterward. Illumina continues to lead in DNA sequencing technology, enhancing global health.
Details
News Market Reaction – ILMN
The recorded move for ILMN in the trading session of this news was +0.48%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Feb. 3, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences:
- SVB Leerink 2022 Global Healthcare Conference on February 17, 2022
Fireside Chat at 9:00am Pacific Time (12:00pm Eastern Time) - Citi 2022 Healthcare Conference on February 24, 2022
Fireside Chat at 9:30am Pacific Time (12:30pm Eastern Time)
The live webcasts can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Dr. Karen Birmingham
+1.646.355.2111
kbirmingham@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conferences-301475244.html
SOURCE Illumina, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.